The Genome's Big Data Problem
By Joseph Cox,
Mother Board
| 06. 04. 2014
Untitled Document
Medicine will be revolutionised in the 21st century, thanks largely to our increasing understanding and collection of genetic data.
Genetic data is information pertaining to part or all of your genome: the DNA structure that makes you you. This is translated into a massive string of letters—approximately six billion characters in length—that can reveal all sorts of things about you.
Thanks to the rise of genome sequencing, prescription medicines could end up being tailored towards individuals, increasing the drugs' effectiveness and minimising their side effects. Treatments could be developed for previously resilient diseases thanks to greater information available for research. It could even be possible to predict how predisposed infants are to various conditions as they grow up.
One program already using genetic data is the Personal Genome Project (PGP), an open call to those who wish to contribute to scientific research. If someone decides to participate in the project, they naturally have to sign a consent form—but it's not as easy as blindly clicking ‘I have read and agree to the Terms and Conditions.’ The New York Times reported that participants need to pass a test...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...